[Course of cellular immunity in urologic neoplasms].
Apart from a purely qualitative evidence concerning the presence of a specific sensibilisation it is possible to estimate also its strength or the blocking factors appearing in the serum of tumour carriers by means of the electrophoresis mobility test. By this it seems to be possible to make an evidence concerning the immunological reaction position of the tumour patient with the possibility to make conclusions as to the prognosis of the patient.
D000951:Antigens, Neoplasm; D002464:Cell Migration Inhibition; D006801:Humans; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology*; D014571:Urologic Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm
Verlaufsstudie zellulärer Immunität bei urologischen Tumorpatienten.